Financial Year |
March 31 2023 |
Monetary Funds |
1,502,785,113.09 |
Held-for-trading Financial Assets |
426,530,237.44 |
Notes Receivable |
587,886.00 |
Accounts Receivable |
68,096,287.17 |
Advances to Suppliers |
19,944,355.94 |
Other Receivables |
29,454,070.76 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
551,036,778.86 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
2,327,907.20 |
Other Current Assets |
48,098,056.36 |
Total Current Assets |
2,648,860,692.82 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
634,279.21 |
Long-term Equity Investment |
309,324,830.00 |
Investment Properties |
159,959,231.46 |
Fixed Assetes |
955,171,296.03 |
Under-construction Projects |
2,903,838.72 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
8,372,840.62 |
Oil and Gas Assets |
-- |
Intangible Assets |
117,005,751.28 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
48,499,943.82 |
Deferred Income Tax Assets |
72,892,033.47 |
Other Non-Current Assets |
111,649,819.11 |
Sub-Total of Non-Current Assets |
2,520,643,073.77 |
Total Assets |
5,169,503,766.59 |
Short-Term Loans |
100,090,277.00 |
Trading Financial liabilities |
-- |
Notes Payable |
9,719,321.87 |
Accounts Payable |
78,135,306.72 |
Accounts Received In Advance |
687,589.89 |
Employee Compensation Payable |
22,707,115.70 |
Taxes Payable |
10,100,306.62 |
Interest Payable |
-- |
Dividend Payable |
510,500.00 |
Other payables |
41,011,985.10 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
137,392,059.94 |
Other Current Liabilities |
5,184,716.48 |
Sub-Total of Current Liabilities |
457,845,427.26 |
Long-term Loans |
250,000,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
2,131,728.96 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
39,410,093.17 |
Other Non-Current Liabilities |
436,365.22 |
Sub-Total of Non-Current Liabilities |
510,456,215.28 |
Total Liabilities |
968,301,642.54 |
Paid-In Capital(Or Share Stock) |
443,235,414.00 |
Capital Surplus |
1,528,007,081.59 |
Surplus Reserve |
316,956,928.10 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,938,850,449.82 |
Minority Stockholder's Interest |
-25,847,749.46 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,227,049,873.51 |
Owner's Equity(Stockholder's Equity) |
4,201,202,124.05 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,169,503,766.59 |